BeiGene Market Cap

BeiGene has a market cap or net worth of 189.31 billion as of May 14, 2025. Its market cap has increased by 47.84% in one year.

Market Cap

189.31B

Enterprise Value

178.26B

Revenue

32.53B

Ranking

n/a

PE Ratio

n/a

Stock Price

134.70

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 6.70B to 189.31B, an increase of 2,726.88%. That is a compound annual growth rate of 43.34%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	185.54B	21.45%
Dec 31, 2024	152.77B	4.09%
Dec 29, 2023	146.76B	-17.60%
Dec 30, 2022	178.11B	-17.96%
Dec 31, 2021	217.12B	19.19%
Dec 31, 2020	182.15B	130.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hansoh Pharmaceutical Group Company	130.51B
JD Health International	121.51B
WuXi Biologics	94.43B
Alibaba Health Information Technology	84.76B
Innovent Biologics	82.48B
Akeso	72.61B
Sichuan Kelun-Biotech Biopharmaceutical	70.13B
Sino Biopharmaceutical	68.71B

Market Cap Rankings